Hemispherx Biopharma (HEB)
Hemispherx Biopharma Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.038M | 0.045M | 0.036M | 0.042M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cost of Revenue | 0.44M | 0.21M | 0.20M | 0.19M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Gross Profit | -0.402M | -0.165M | -0.164M | -0.148M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Research & Development Expense | 1.71M | 1.75M | 1.62M | 1.64M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Selling, General, & Admin. Expense | 1.82M | 1.63M | 1.45M | 1.79M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 3.97M | 3.59M | 3.27M | 3.62M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Operating Income | -3.932M | -3.545M | -3.234M | -3.578M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Non-Operating Income | 0.791M | 0.811M | 0.954M | 2.724M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Pretax Income | -3.12M | -2.74M | -2.29M | -0.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Provision for Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Income after Tax | -3.12M | -2.74M | -2.29M | -0.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -3.115M | -2.74M | -2.294M | -0.866M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Income | -3.115M | -2.74M | -2.294M | -0.866M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 155.75 | 135.50 | 114.70 | 135.26 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Average Shares used to compute basic EPS | 155.75 | 135.50 | 114.70 | 135.26 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| EPS - Basic net | -0.02 | -0.02 | -0.02 | -0.01 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| EPS - Diluted net | -0.02 | -0.02 | -0.02 | -0.01 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
